Dr. Sarin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-721-3476
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 2009 - 2012
- Santa Clara Valley Medical CenterInternship, Transitional Year, 2008 - 2009
- Stanford University School of MedicinePh.D., Genetics, 2008 - 2009
- Stanford University School of MedicineClass of 2008
- Stanford UniversityPhD, Genetics, 2000 - 2006
- Stanford UniversityB.S., Computer Science, 1996 - 2000
Certifications & Licensure
- CA State Medical License 2009 - 2026
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Medical Career Development Award Dermatology Foundation, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- F32 NRSA Ruth L. Kirschstein National Research Service Awards NIH, 2013
- Join now to see all
Clinical Trials
- Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer Start of enrollment: 2018 Jul 07
- Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis Start of enrollment: 2018 Dec 01
- Complement C5a Receptors in Hidradenitis Suppurativa Start of enrollment: 2019 Jul 18
Publications & Presentations
PubMed
- Identification of activating hotspot mutations in acrochordons through next-generation sequencing.Justin L Jia, Jennifer Y Wang, Warren H Chan, Julien Lanoue, Hanh Do
JAAD International. 2025-02-01 - When savings fall short: Drug coupons for generic prescriptions do not always result in savings for patients.Melissa C Leeolou, Justin L Jia, Dayna Pham, Kavita Y Sarin
Journal of the American Academy of Dermatology. 2024-11-07 - Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis.Gabriel J Starrett, Brittany C Baikie, Benjamin K Stoff, Hans E Grossniklaus, Inga Van Buren
Clinical Cancer Research. 2024-11-01
Journal Articles
- Sexual and Gender Minority Curricula Within US Dermatology Residency ProgramsKristin M Nord, Kavita Y Sarin, JAMA Dermatology
- Dermatomyositis associated with capecitabine in the setting of malignancyChen FW, Zhou X, Egbert BM, Swetter SM, Sarin KY, J Am Acad Dermatol, 1/1/2014
- Activating HRAS Mutation in Nevus SpilusSarin KY, McNiff JM, Kwok S, Kim J, Khavari PA, J Invest Dermatol, 1/1/2014
- Join now to see all
Press Mentions
- Mobile App Helps Detect Skin Cancer in Older PatientsJuly 18th, 2022
- New Gel Shows Promise Against BCCAugust 12th, 2021
- Positive Data from the Remetinostat Phase II Study in Basal Cell Carcinoma Published in Clinical Cancer ResearchAugust 12th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: